Medicine and Dentistry
Neoplasm
100%
Surgery
39%
Tumor Necrosis Factor
35%
Pancreas Islet Cell Tumor
33%
Diseases
28%
Neuroendocrine Tumor
24%
Malignant Neoplasm
23%
Nesidioblastosis
22%
Metastatic Carcinoma
21%
Cancer
21%
Von Hippel-Lindau Disease
20%
Multiple Endocrine Neoplasia Type I
19%
Liver Metastasis
17%
Melphalan
16%
Endothelial Cell
15%
Angiogenesis
15%
Gene Expression
14%
Hyperparathyroidism
13%
Melanoma
13%
Cancer Therapy
13%
Tumor Progression
13%
Endostatin
13%
Parathyroid
12%
Parathyroid Hormone
12%
Primary Hyperparathyroidism
12%
Endothelial Monocyte Activating Polypeptide II
12%
Fibrinogen
12%
Colorectal Carcinoma
11%
Synapsin I
11%
Filamin A
10%
Cytokine
10%
Indocyanine Green
9%
Angiogenesis Inhibitor
9%
Peritoneum Mesothelioma
9%
Radiofrequency Ablation
9%
Tumor Vascularization
9%
Promoter Region
8%
Thyroid Cancer
8%
Adenoma
8%
Magnetic Resonance Imaging
8%
Isotopes of Calcium
8%
Parathyroidectomy
8%
Reoperation
8%
Diagnosis
7%
Parathyroid Adenoma
7%
Positron Emission Tomography
7%
Methylation
7%
Limb Perfusion
7%
Surgical Anastomosis
7%
Fine-Needle Aspiration
7%
Keyphrases
Tumor
68%
Pancreatic Neuroendocrine Tumors (pNETs)
42%
Tumor Necrosis Factor-α
41%
Multiple Endocrine Neoplasia Type 1 (MEN1)
31%
Angiogenesis
26%
Isolated Hepatic Perfusion
24%
Insulinoma
23%
Fibrinogen
19%
Resection
19%
Hyperthermia
18%
Endostatin
17%
Liver
17%
Von Hippel-Lindau Disease
17%
Endothelial Monocyte-activating polypeptide-II
17%
Tumor Growth
16%
Melphalan
16%
Neuroendocrine Tumor
15%
Hyperparathyroidism
14%
Endothelial Cells
14%
Soldering
13%
Diode Laser
13%
Laser Welding
12%
Interacting Proteins
12%
Filamin A
12%
Radiofrequency Ablation
12%
Cancer Therapy
11%
Glands
10%
Antiangiogenic Therapy
10%
Isolated Limb Perfusion
10%
Primary Hyperparathyroidism (pHPT)
9%
Liver Metastasis
9%
Mouse Model
9%
Tumor Vasculature
9%
Pancreatic Cancer
9%
Adenovirus
8%
Parathyroidectomy
8%
Clinical Trials
8%
Phase II Study
8%
Peritoneal Perfusion
8%
Gene Therapy
8%
Cisplatin
8%
Gene Expression
8%
Insulin
8%
COVID-19
8%
Reoperation
8%
Parathyroid Adenoma
8%
Angiogenesis Inhibitors
8%
Surgical Resection
7%
Vascular Endothelial Growth Factor
7%
Antiangiogenic Agents
7%